Patents by Inventor Yu-Ling Chen

Yu-Ling Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6741261
    Abstract: A compositing system (300) that comprises an optimized alpha-channel compositing module (303) is disclosed. The compositing system (300) optimizes the range correction in the alpha-channel compositing module (303) by using a constant divider (401) and delaying the correction of an alpha value until after the summation of the alpha values from all contributing regions. Uncorrected opacity values are used to index a look-up table in order to reduce the data processing path to a multiplier (407) for processing after premultiplication of a color values from all contributing regions.
    Type: Grant
    Filed: February 12, 2001
    Date of Patent: May 25, 2004
    Assignee: Canon Kabushiki Kaisha
    Inventor: Yu-Ling Chen
  • Patent number: 6570510
    Abstract: The apparatus comprises a discrete wavelet transform (DWT) engine, a code block manager, and an entropy encoder. The code block manager comprises at least one controller, which losslessly compresses the transform coefficients and stores them in a code block storage for buffering. The entropy coder comprises at least one entropy encoder, each comprising a decoder for decoding the losslessly compressed transformed coefficients prior to entropy encoding.
    Type: Grant
    Filed: December 6, 2001
    Date of Patent: May 27, 2003
    Assignee: Canon Kabushiki Kaisha
    Inventors: Yu-Ling Chen, James Philip Andrew
  • Publication number: 20020107669
    Abstract: A method, an apparatus (100) and a computer program product for entropy coding of discrete wavelet transform (DWT) coefficient bits that are arranged into code blocks and coded in bitplane order using three coding passes for each bitplane are disclosed. In the method, transform coefficients of a code block (200) in sign-magnitude form are pre-analyzed. Statistical data about the coefficients is stored, preferably with the coefficients. Significance state data (330), coded data (340), magnitude refinement data (350), bit data (310), and sign data (320) for the code block are buffered. More preferably, the buffering is implemented using a FIFO (120, 1130), located between a context generation module (110, 1120) and an arithmetic coder (130, 1150). Based upon the statistical data, at least one command for at least one sequence of bit and context pairs is generated for arithmetic encoding.
    Type: Application
    Filed: November 14, 2001
    Publication date: August 8, 2002
    Inventor: Yu-Ling Chen
  • Publication number: 20010052906
    Abstract: A compositing system (300) that comprises an optimized alpha-channel compositing module (303) is disclosed. The compositing system (300) optimizes the range correction in the alpha-channel compositing module (303) by using a constant divider (401) and delaying the correction of an alpha value until after the summation of the alpha values from all contributing regions. Uncorrected opacity values are used to index a look-up table in order to reduce the data processing path to a multiplier (407) for processing after premultiplication of a color values from all contributing regions.
    Type: Application
    Filed: February 12, 2001
    Publication date: December 20, 2001
    Inventor: Yu-Ling Chen
  • Patent number: 4573995
    Abstract: A method for transdermal delivery of naloxone, naltrexone and nalbuphine base through intact skin is described. Preferred embodiments of transdermal therapeutic systems for delivering these drugs and polyethylene glycol monolaurate employ an ethylene vinylacetate matrix containing drug base at a concentration above saturation and polyethylene glycol monolaurate below unit activity. Polyethylene glycol manolaurate is disclosed as a permeation enhancer for the base form of these drugs and is preferably delivered simultaneously with the drug.
    Type: Grant
    Filed: October 9, 1984
    Date of Patent: March 4, 1986
    Assignee: ALZA Corporation
    Inventors: Yu-Ling Chen, Leslie L. Chun, David J. Enscore